Neuromarketing and consumer neuroscience: Contributions to neurology

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Javor, Andrija ^a   Koller, Monika ^b   Lee, Nick ^c   Chamberlain, Laura ^c   Ransmayr, Gerhard ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

Compulsive buying; Consumer neuroscience; Ethics; Neurology; Neuromarketing; Pathological gambling; Reward; Trust

Indexed keywords

ARTICLE; CLINICAL RESEARCH; COGNITION; CONSUMER; EPILEPSY; FRONTOTEMPORAL DEMENTIA; HUMAN; HUNTINGTON CHOREA; KNOWLEDGE; MEDICAL ETHICS; NEUROLOGIST; NEUROLOGY; NEUROSCIENCE; PARKINSON DISEASE; REWARD; TRUST;

HUMANS; MARKETING OF HEALTH SERVICES; NEUROLOGY; NEUROSCIENCES;

EID: 84873275207     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-13     Document Type: Article

References (178)

1. Frazzetto G, Anker S. Neuroculture. Nat Rev Neurosci 2009, 10:815-821.
2. Churchland PS. Neurophilosophy: toward a unified science of the mind 1986, Cambridge, MA: MIT Press.
3. Ashbrook J. Neurotheology: the working brain and the work of theology. Zygon J Sci Theol 1984, 19:331-350.
4. Tallis R. Aping mankind: neuromania, darwinitis and the misrepresentation of humanity 2011, London: Acumen.
5. Senior C, Lee N, Butler M. Perspective: organizational cognitive neuroscience. Orga Sci 2011, 22(3):804-815.
6. Camerer CF, Loewenstein G, Prelec D. Neuroeconomics: why economics needs brains. Scand J Econ 2004, 106(3):555-579.
7. Glimcher PW, Rustichini A. Neuroeconomics: the consilience of brain and decision. Science 2004, 306:447-452. 10.1126/science.1102566, 15486291.
8. Zak PJ. Neuroeconomics. Philos Trans R Soc Lond B Biol Sci 2004, 359:1737-1748. 1693452, 15590614.
9. Braeutigam S. Neuroeconomics-from neural systems to economic behaviour. Brain Res Bull 2005, 67:355-360. 10.1016/j.brainresbull.2005.06.009, 16216681.
10. Fehr E, Fischbacher U, Kosfeld M. Neuroeconomic foundations of trust and social preferences: initial evidence. Am Econ Rev 2005, 95:346-351.
11. Kenning P, Plassmann H. NeuroEconomics: an overview from an economic perspective. Brain Res Bull 2005, 67:343-354. 10.1016/j.brainresbull.2005.07.006, 16216680.
12. Sanfey AG, Loewenstein G, McClure SM, Cohen JD. Neuroeconomics: cross-currents in research on decision-making. Trends Cogn Sci 2006, 10:108-116. 10.1016/j.tics.2006.01.009, 16469524.
13. Smidts A. Kijken in het brein: over de mogelijkheden van neuromarketing 2002, Dutch: Inaugural Address Erasmus University: ERIM EIA-12-MKT.
14. Lee N, Chamberlain L. Neuroimaging and psychophysiological measurement in organizational research: an agenda for research in organizational cognitive neuroscience. Ann NY Acad Sci 2007, 1118:18-42. 10.1196/annals.1412.003, 17717097.
15. Dawson ME, Schell AM, Filion DL. The electrodermal system. Handbook of psychophysiology 2000, 200-223. Boston: Cambridge: University Press, Cacioppo JT, Tassinary LG, Bernston GG.
16. Ohme R, Reykowska D, Wiener D, Choromanska A. Analysis of neurophysiological reactions to advertising stimuli by means of EEG and galvanic skin response measures. J Neurosci Psychol Econ 2009, 2:21-31.
17. Glimcher PW, Camerer CF, Fehr E, Poldrack RA. Introduction: a brief history of neuroeconomics. Neuroeconomics: decision making and the brain 2009, 1-12. Amsterdam: Academic, Glimcher PW, Camerer CF, Fehr E, Poldrack RA.
18. Reimann M, Schilke O, Weber B, Neuhaus C, Zaichkowsky J. Functional magnetic resonance imaging in consumer research: a review and application. Psychol Mark 2011, 28(6):608-637.
19. Lee N, Senior C, Butler MJR. The domain of organizational cognitive neuroscience: theoretical and empirical challenges. J Manag 2012, 38(4):921-931.
20. Plassmann H, Zoega Ramsoy T, Milosavljevic M. Branding the brain - a critical review and outlook. J Consum Psychol 2012, 22:18-36.
21. Fisher CE, Chin L, Klitzman R. Defining neuromarketing: practices and professional challenges. Harv Rev Psychiatry 2010, 18(4):230-237. 10.3109/10673229.2010.496623, 3152487, 20597593.
22. Dumit J. Is it me or my brain? depression and neuroscientific facts. J Med Humanit 2003, 24:35-47.
23. Hubert M, Kenning P. A current overview of consumer neuroscience. J Consum Behav 2008, 7:272-292.
24. Singer E. They know what you want. New Sci 2004,
25. Thompson J. They don't just want your money, they want your brain. London Independent on Sunday 2005,
26. Dias D. A 'Buy Button' in your brain?. National Post 2006,
27. Fullerton RA. " A virtual social H-bomb" : the late 1950s controversy over subliminal advertising. Journal of Historical Research in Marketing 2010, 2(2):166-173.
28. Pratkanis AR, Greenwald AG. Recent perspectives on unconscious processing: still no marketing applications. Psychol Mark 1988, 5(4):339-355.
29. Lee N, Broderick AJ, Chamberlain L. What is neuromarketing? a discussion and agenda for future research. Int J Psychophysiol 2007, 63(2):199-204. 10.1016/j.ijpsycho.2006.03.007, 16769143.
30. Becker WJ, Cropanzano R, Sanfey AG. Organizational neuroscience: taking organizational theory inside the neural black box. J Manag 2011, 37:933-961.
31. Herman S. Selling to the brain. Glob Cosmet Ind 2005, 173(5):64-66.
32. Huang G. The economics of brains. Technol Rev 1998, 108(5):74-76.
33. Lovel J. Nader group slams Emory for brain research 2003, Chronicle: Atlanta Business.
34. Editorial. Brain scam?. Nat Neurosci 2004, 7(10):1015. 10.1038/nn1004-1015, 15452565.
35. Laybourne P, Lewi D. Neuromarketing: the future of consumer research?. Admap 2005, 461:28-30.
36. Willingham DT, Dunn EW. What neuroimaging and brain localization can do, cannot do, and should not do for social psychology. J Personal Soc Psychol 2003, 85(4):662-671.
37. Sharp C, Monterosso J, Montague PR. Neuroeconomics: a bridge for translational research. Biol Psychiatry 2012, 72(2):87-92. 10.1016/j.biopsych.2012.02.029, 22727459.
38. Shiv B, Fedorikhin A. Heart and mind in conflict: the interplay of affect and cognition in consumer decision making. J Consum Res 1999, 26:278-292.
39. Shiv B. Emotions, decisions, and the brain. J Consum Psychol 2007, 17(3):174-178.
40. Cohen JD. The vulcanization of the human brain: a neural perspective on interactions between cognition and emotion. J Econ Perspect 2005, 19(4):3-24.
41. American academy of neurology http://www.aan.com/globals/axon/assets/2726.pdf.
42. Lee N, Senior C, Butler MJR. Leadership research and cognitive neuroscience: the state of this union. Leadersh Q 2011, 23:213-218.
43. Peterson RL. The neuroscience of investing: fMRI of the reward system. Brain Res Bull 2005, 67:391-7. 10.1016/j.brainresbull.2005.06.015, 16216685.
44. Spencer H. Principles of psychology 1880, New York: Appleton Press.
45. Bechara A, Damasio AR. The somatic marker hypothesis: a neural theory of economic decision. Games and Economic Behavior 2005, 52:336-372.
46. Buchel C, Dolan RJ. Classical fear conditioning in functional neuroimaging. Curr Opin Neurobiol 2000, 10:219-233. 10.1016/S0959-4388(00)00078-7, 10753800.
47. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci 2001, 4:95-102. 10.1038/82959, 11135651.
48. Ploghaus A, Tracey I, Gati JS, Clare S, Menon RS, Matthews PM, Rawlins JNP. Dissociating pain from its anticipation in the human brain. Science 1999, 284:1979-1981. 10.1126/science.284.5422.1979, 10373114.
49. Rolls ET. The brain and emotion 1999, Oxford: Oxford University Press.
50. Rolls ET. The orbitofrontal cortex and reward. Cereb Cortex 2000, 10:284-294. 10.1093/cercor/10.3.284, 10731223.
51. Schultz W, Tremblay L, Hollerman JR. Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex 2000, 10:272-283. 10.1093/cercor/10.3.272, 10731222.
52. Schultz W, Dayan P, Montague RA. Neural substrate of prediction and reward. Science 1997, 275:1593-1599. 10.1126/science.275.5306.1593, 9054347.
53. Erk S, Martin S, Walter H. Emotional context during encoding of neutral items modulates brain activation not only during encoding but also during recognition. NeuroImage 2005, 26(3):829-838. 10.1016/j.neuroimage.2005.02.045, 15955493.
54. Breiter HC, Aharon I, Kahneman D, Dale A, Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001, 30:619-639. 10.1016/S0896-6273(01)00303-8, 11395019.
55. Gray JA. The neuropsychology of emotion and personality. Cognitive neurochemistry 1987, 171-90. Oxford: Oxford University Press, Stahl SM, Iversen SD, Goodman ED.
56. Fournier S. Consumers and their brands: developing relationship theory in consumer research. J Consum Res 1998, 24:343-53.
57. Priester JR, Nayakankuppam D, Fleming MA, Godek J. The A2sc2 model: the influence of attitudes and attitude strength on consideration and choice. J Consum Res 2004, 30:574-84.
58. Park CW, MacInnis DJ, Priester J, Eisingerich AB, Iacobucci D. Brand attachment and brand attitude strength: conceptual and empirical differentiation of two critical brand equity drivers. J Mark 2010, 74:1-17.
59. Miller EK, Cohen JD. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001, 24:167-202. 10.1146/annurev.neuro.24.1.167, 11283309.
60. Ballard IC, Murty VP, Carter RM, MacInnes JJ, Huettel SA, Adcock RA. Dorsolateral prefrontal cortex drives mesolimbic dopaminergic regions to initiate motivated behavior. J Neurosci 2011, 31:10340-10346. 10.1523/JNEUROSCI.0895-11.2011, 3182466, 21753011.
61. Fellows LK, Farah MJ. The role of ventromedial prefrontal cortex in decision making: judgment under uncertainty or judgment per se?. Cereb Cortex 2007, 17:2669-2674. 10.1093/cercor/bhl176, 17259643.
62. Paulus MP, Frank LR. Ventromedial prefrontal cortex activation is critical for preference judgments. NeuroReport 2003, 14:1311-1315.
63. Santos JP, Seixas D, Brandão S, Moutinho L. Investigating the role of the ventromedial prefrontal cortex in the assessment of brands. Front Neurosci 2011, 5:77. 3108388, 21687799.
64. McClure SM, Li J, Tomlin D, Cypert KS, Montague LM, Montague PR. Neural correlates of behavioral preference for culturally familiar drinks. Neuron 2004, 44:379-87. 10.1016/j.neuron.2004.09.019, 15473974.
65. Prelec D, Loewenstein GF. The red and the black: mental accounting of savings and debt. Mark Sci 1998, 17:4-28.
66. Knutson B, Rick S, Wimmer GE, Prelec D, Loewenstein G. Neural predictors of purchases. Neuron 2007, 53:147-156. 10.1016/j.neuron.2006.11.010, 1876732, 17196537.
67. Ariely D, Berns GS. Neuromarketing: the hope and hype of neuroimaging in business. Nat Rev Neurosci 2010, 11:284-292. 10.1038/nrn2795, 2875927, 20197790.
68. Erk S, Spitzer M, Wunderlich AP, Galley L, Walter H. Cultural objects modulate reward circuitry. NeuroReport 2002, 13:2499-2503. 10.1097/00001756-200212200-00024, 12499856.
69. Peterson RL. Insight the investor's brain: the power of mind over money 2007, Hoboken: Wiley.
70. Plassmann H, Kenning P, Ahlert D. Why companies should make their customers happy: the neural correlates of customer loyalty. Adv Consum Res 2007, 34:735-739.
71. Deppe M, Schwindt W, Kugel H, Plassmann H, Kennig P. Nonlinear responses within the medial prefrontal cortex reveal when specific implicit information influences economic decision making. J Neuroimaging 2005, 15:171-182.
72. Schaefer M, Rotte M. Favorite brands as cultural objects modulate reward circuit. NeuroReport 2007, 18:141-145. 10.1097/WNR.0b013e328010ac84, 17301679.
73. Plassmann H, O'Doherty J, Shiv B, Rangel A. Marketing actions can modulate neural representations of experienced pleasantness. Proc Natl Acad Sci USA 2008, 105:1050-1054. 10.1073/pnas.0706929105, 2242704, 18195362.
74. Johnsrude IS, Owen AM, White NM, Xhao WV, Bohbot V. Impaired preference conditioning after anterior temporal lobe resection in humans. J Neurosci 2000, 20:2649-2656.
75. Kouider S, Dehaene S. Levels of processing during non-conscious perception: a critical review of visual masking. Philos Trans R Soc Lond B Biol Sci 2007, 362(1481):857-875. 10.1098/rstb.2007.2093, 2430002, 17403642.
76. Rangel A, Camerer C, Montague PR. A framework for studying the neurobiology of value-based decision making. Nat Rev Neurosci 2008, 9(7):545-556. 10.1038/nrn2357, 18545266.
77. Klucharev V, Smidts A, Fernández G. Brain mechanisms of persuasion: how 'expert power' modulates memory and attitudes. SCAN 2008, 3:353-366. 2607059, 19015077.
78. Stallen M, Smidts A, Rijpkema M, Smit G, Klucharev V, Fernández G. Celebrities and shoes on the female brain: the neural correlates of product evaluation in the context of fame. J Econ Psychol 2010, 31:802-811.
79. American Psychiatric Association Diagnostic and statistical manual of mental disorders (4th ed.) 1994, Washington, DC: American Psychiatric Association, American Psychiatric Association.
80. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J. Prevalence of repetitive and reward-seeking behaviors in Parkinson's disease. Neurology 2006, 67:1254-1257. 10.1212/01.wnl.0000238503.20816.13, 16957130.
81. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007, 68:301-303. 10.1212/01.wnl.0000252368.25106.b6, 17242339.
82. Nakaaki S, Murata Y, Sato J, Shinagawa Y, Hongo J, Tatsumi H, Mimura M, Furukawa TA. Impairment of decision-making cognition in a case of frontotemporal lobar degeneration (FTLD) presenting with pathologic gambling and hoarding as the initial symptoms. Cogn Behav Neurol 2007, 20:121-125. 10.1097/WNN.0b013e31804c6ff7, 17558256.
83. Cavanna AE, Mula M, Strigaro G, Servo S, Tota G, Barbagli D, Collimedaglia L, Viana M, Cantello R, Monaco F. Clinical correlates of pathological gambling symptoms in patients with epilepsy. Epilepsia 2008, 49:1460-1464. 10.1111/j.1528-1167.2008.01586.x, 18479402.
84. De Marchi N, Morris M, Mennella R, La Pia S, Nestadt G. Association of obsessive-compulsive disorder and pathological gambling with Huntington's disease in an Italian pedigree: possible association with Huntington's disease mutation. Acta Psychiatr Scand 1998, 97:62-65. 10.1111/j.1600-0447.1998.tb09964.x, 9504705.
85. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol Med 1997, 27:473-475. 10.1017/S0033291796003789, 9089839.
86. Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, Grosset DG. Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 2006, 21:2206-2208. 10.1002/mds.21110, 17013907.
87. Reuter J, Raedler T, Rose M, Hand I, Gläscher J, Buechel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005, 8:147-148. 10.1038/nn1378, 15643429.
88. Ross D, Sharp C, Vuchinich R, Spurrett D. Midbrain mutiny: the picoeconomics and neuroeconomics of disordered gambling 2008, Cambridge, MA: The MIT Press.
89. Hollander E, Allen A. Is compulsive buying a real disorder, and is it really compulsive? (editorial). Am J Psychiatry 2006, 163:1670-1672. 10.1176/appi.ajp.163.10.1670, 17012670.
90. Ridgway NM, Kukar-Kinney M, Monroe KB. An expanded conceptualization and a new measure of compulsive buying. J Consum Res 2008, 35:622-639.
91. Grant JE, Brewer JA, Potenza MN. The neurobiology of substance and behavioural addictions. CNS Spectr 2006, 11:924-30.
92. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol 2001, 58:1803-1809. 10.1001/archneur.58.11.1803, 11708987.
93. Lejoyeux M, Hourtané M, Adès J. Compulsive buying and depression. J Clin Psychiatry 1995, 56(1):38.
94. Nestler EJ, Carlezon WA. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006, 59:1151-1159. 10.1016/j.biopsych.2005.09.018, 16566899.
95. Raab G, Elger CE, Neuner M, Weber B. A neurological study of compulsive buying behaviour. J Consum Policy 2011, 34:401-413.
96. Pedersen CA. How love evolved from sex and gave birth to intelligence and human nature. J Bioecon 2004, 6:39-63.
97. Zak PJ, Knack S. Trust and growth. Econ J 2001, 111(470):295-321.
98. Coleman JS. Foundations of social theory 1990, Cambridge, London: Harvard University Press.
99. Lewicki RJ, McAllister DJ, Bies RJ. Trust and distrust: new relationships and realities. Acad Manag Rev 1998, 23:438-458.
100. Berg J, Dickhaut J, McCabe K. Trust, reciprocity, and social-history. Games and Economic Behavior 1995, 10:122-142.
101. McCabe K, Smith V. A two person trust game played by naive and sophisticated subjects. Proc Natl Acad Sci USA 2002, 97:3777-3781.
102. Zak PJ, Kurzban R, Matzner WT. The neurobiology of trust. Annals of the NY Academy of Sciences 2004, 1032:224-227.
103. Fehr E. On the economics and biology of trust. J Eur Econ Assoc 2009, 7:235-266.
104. Riedl R, Javor A. The biology of trust: integrating evidence from genetics, endocrinology, and functional brain imaging. Journal of Neuroscience, Psychology, and Economics 2012, 5:63-91.
105. Winston JS, Strange BA, O'Doherty J, Dolan RJ. Automatic and intentional brain responses during evaluation of trustworthiness of faces. Nat Neurosci 2002, 5(3):277-283. 10.1038/nn816, 11850635.
106. Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron 2008, 58:639-650. 10.1016/j.neuron.2008.04.009, 18498743.
107. King-Casas B, Tomlin D, Anen C, Camerer CF, Quartz SR, Montague PR. Getting to know you: reputation and trust in a two-person economic exchange. Science 2005, 308(5718):78-83. 10.1126/science.1108062, 15802598.
108. Krueger F, McCabe K, Moll J, Kriegeskorte N, Zahn R, Strenziok M, Heinecke A, Grafman J. Neural correlates of trust. Proc Natl Acad Sci USA 2007, 104(50):20084-20089. 10.1073/pnas.0710103104, 2148426, 18056800.
109. Frith U. Mind blindness and the brain in autism. Neuron 2001, 32:969-979. 10.1016/S0896-6273(01)00552-9, 11754830.
110. Delgado MR, Frank RH, Phelps EA. Perceptions of moral character modulate the neural systems of reward during the trust game. Nat Neurosci 2005, 8(11):1611-1618. 10.1038/nn1575, 16222226.
111. Zak PJ, Kurzban R, Matzner WT. Oxytocin is associated with human trustworthiness. Horm Behav 2005, 48(5):522-527. 10.1016/j.yhbeh.2005.07.009, 16109416.
112. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature 2005, 435(7042):673-676. 10.1038/nature03701, 15931222.
113. Shahrokh DK, Zhang TY, Diorio J, Gratton A, Meaney MJ. Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 2010, 151(5):2276-86. 10.1210/en.2009-1271, 2869254, 20228171.
114. Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 1999, 31:6-41. 10.1016/S0165-0173(99)00023-5, 10611493.
115. Stallen M, De Dreu CKW, Shalvi S, Smidts A, Sanfey AG. The herding hormone: Oxytocin stimulates in-group conformity. Psychol Sci 2012, 23(11):1288-1292. 10.1177/0956797612446026, 22991128.
116. DeDreu CKW, Greer LL, Handgraaf MJJ, Shalvi S, Van Kleef GA, Baas M. The neuropeptide oxytocin regulates parochial altruism in intergroup conflict among humans. Science 2010, 328:1408-1411. 10.1126/science.1189047, 20538951.
117. De Dreu CKW, Shalvi S, Greer LL, Van Kleef GA, Handgraaf MJ. Oxytocin motivates non-cooperation in intergroup conflict to protect vulnerable in-group members. PLoS One 2012, 7(11):e46751. 10.1371/journal.pone.0046751, 3492361, 23144787.
118. Takahashi T, Ikeda K, Ishikawa M, Kitamura N, Tsukasaki T, Nakama D, Kameda T. Interpersonal trust and social stress-induced cortisol elevation. NeuroReport 2005, 16:197-199. 10.1097/00001756-200502080-00027, 15671877.
119. Alesina A, La Ferrara E. Who trusts others?. Journal of Public Economic 2002, 85:207-234.
120. Riedl R, Hubert M, Kenning P. Are there neural gender differences in online trust? an fMRI study on the perceived trustworthiness of ebay offers. MIS Q 2010, 34:397-428.
121. Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 2007, 62(8):847-855. 10.1016/j.biopsych.2007.03.001, 2711771, 17544382.
122. Zak PJ, Borya K, Matzner WT, Kurzban R. The neuroeconomics of distrust: sex differences in behavior and physiology. Am Econ Rev 2005, 95:360-363.
123. Lau G, Lee S. Consumers' trust in a brand and the link to brand loyalty. J Mark-Focus Manag 1999, 4:341-70.
124. Chaudhuri A, Holbrook MB. The chain of effects from brand trust and brand affect to brand performance: the role of brand loyalty. J Mark 2001, 65:81-93.
125. Pavlou PA. Consumer acceptance of electronic commerce: integrating trust and risk with the technology acceptance model. Int J Electron Commer 2003, 7:101-134.
126. Gefen D. Reflections on the dimensions of trust and trustworthiness among online consumers. Database 2002, 33:38-53.
127. Dimoka A. What does the brain tell us about trust and distrust? evidence from a functional neuroimaging study. MIS Q 2010, 34:373-396.
128. Morgan RM, Hunt SD. The commitment-trust theory of relationship marketing. J Mark 1994, 58:20-38.
129. Das K. Relationship marketing research (1994-2006): an academic literature review and classification. Marketing Intelligence and Planning 2009, 27(3):326-363.
130. Rilling JK, Sanfey AG. The neuroscience of social decision-making. Annu Rev Psychol 2011, 62:23-48. 10.1146/annurev.psych.121208.131647, 20822437.
131. Lee YY, Lin JL. The effects of trust in physician on self-efficacy, adherence and diabetes outcomes. Soc Sci Med 2009, 68:1060-1068. 10.1016/j.socscimed.2008.12.033, 19162386.
132. Nguyen GC, Laveist TA, Harris ML, Datta LW, Bayless TM, Brant SR. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:1233-1239. 10.1002/ibd.20883, 2799328, 19177509.
133. Thom DH, Campbell B. Patient-physician trust: an exploratory study. J Fam Pract 1997, 44:169-76.
134. Thom DH, Ribisl KM, Stewart AL, Luke DA. Validation of a measure of patients' trust in their physician: the trust in physician scale. Med Care 1999, 37:510-17. 10.1097/00005650-199905000-00010, 10335753.
135. Safran DG, Taira DA, Rogers WH, Kosinski M, Ware JE, Tarlov AR. Linking primary care performance to outcomes of care. J Fam Pract 1998, 47:213-20.
136. Thom DH, . Stanford Trust Study Physicians Physician behaviors that predict patient trust. J Fam Pract 2001, 50:323-328. Stanford Trust Study Physicians.
137. Gibbons J, McHugh P. Plasma cortisol in depressive illness. J Psychiatry Res 1962, 1:162-171.
138. Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000, 48:791-800. 10.1016/S0006-3223(00)00994-X, 11063975.
139. Smith NC, Cooper-Martin E. Ethics and target marketing: the role of product harm and consumer vulnerability. J Mark 1997, 61(3):1-20.
140. Sillup GP, Porth SL. Ethical issues in the pharmaceutical industry: an analysis of US newspapers. International Journal of Pharmaceutical and Healthcare Marketing 2008, 2(3):163-180.
141. Madan CR. Neuromarketing: the next step in market research?. Eureka 2010, 1(1).
142. Farah MJ. Neuroethics: the practical and the philosophical. Trends Cogn Sci 2005, 9:34-40. 10.1016/j.tics.2004.12.001, 15639439.
143. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research. JAMA 2003, 289:454-65. 10.1001/jama.289.4.454, 12533125.
144. Rennie D. Thyroid storm. JAMA 1997, 277:1238-1243. 10.1001/jama.1997.03540390068038, 9103350.
145. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000, 342:1539-1544. 10.1056/NEJM200005183422024, 10816196.
146. Murphy PE. Ethics in advertising: review, analysis, and suggestions. Journal of Public Policy & Marketing 1998, 17(2):316-319.
147. Laczniak GR. Marketing ethics: onward toward greater expectations. Journal of Public Policy & Marketing 1993, 12(1):91-96.
148. Robin DP, Reidenbach RE. Searching for a place to stand: toward a workable ethical philosophy for marketing. Journal of Public Policy & Marketing 1993, 12(1):97-105.
149. Gaski JF. Does marketing ethics really have anything to say? - a critical inventory of literature. Journal of Business Ethics 1999, 18:315-334.
150. Brinkmann J. Business and marketing ethics as professional ethics. Concepts, approaches and typologies. Journal of Business Ethics 2002, 41:159-177.
151. World Medical Association Helsinki declaration http://www.wma.net/en/30publications/10policies/b3/index.html, World Medical Association.
152. Murphy ER, Illes J, Reiner PB. Neuroethics of neuromarketing. J Consum Behav 2008, 7:293-302.
153. New York times http://www.nytimes.com/2012/06/17/technology/acxiom-the-quiet-giant-of-consumer-database-marketing.html?pagewanted=all.
154. Kulynych J. Legal and ethical issues in neuroimaging research: human subjects protection, medical privacy, and the public communication of research results. Brain Cogn 2002, 50:345-357. 10.1016/S0278-2626(02)00518-3, 12480482.
155. Tovino SA. Functional neuroimaging and the law: trends and directions for future scholarship. Am J Bioeth 2007, 7:44-56.
156. Tovino SA. The confidentiality and privacy implications of functional magnetic resonance imaging. J Law Med Ethics 2005, 33:844-850. 10.1111/j.1748-720X.2005.tb00550.x, 16686253.
157. Illes J. Empirical neuroethics. Can brain imaging visualize human thought? Why is neuroethics interested in such a possibility?. EMBO Rep 2007, 8(Spec No):57-60.
158. Illes J, Racine E. Imaging or imagining? a neuroethics challenge informed by genetics. Am J Bioeth 2005, 5:5-18. 1506750, 16036688.
159. Greely HT. The social effects of advances in neuroscience: legal problems, legal perspectives. Neuroethics: defining the issues in theory, practice, and policy 2006, 245-264. Oxford: Oxford University Press, Illes J.
160. Alpert S. Brain privacy: how can we protect it?. Am J Bioeth 2007, 7:70-73.
161. Appelbaum PS. Law & psychiatry: the new lie detectors: neuroscience, deception, and the courts. Psychiatr Serv 2007, 58:460-462. 10.1176/appi.ps.58.4.460, 17412845.
162. Grimes A. Are we listening and learning? understanding the nature of hemispherical lateralisation and its application to marketing. Int J Mark Res 2006, 48:439-458.
163. Lindstrom M. Buyology: truth and lies about what we buy 2010, New York, NY: Broadway Business.
164. Heinemann T, Hoppe C, Listl S, Spickhoff A, Elger CE. Incidental findings in neuroimaging: ethical problems and solutions. Dtsch Arztebl 2007, 104(27):A1982-7.
165. Heinemann T, Hoppe C, Weber B, Elger CE. Ethically appropriate handling of incidental findings in human neuroimaging research. Clin Neuroradiol 2009, 19(3):242-243.
166. Hentschel F, Von Kummer R. Concentrating on the next version: reply to the letter by Thomas Heinemann et al. To the guest editorial of frank hentschel and rüdiger von kummer. Clin Neuroradiol 2009, 19(3):244.
167. Hentschel F, VonKummer R. Response of the german society of neuroradiology to the guideline " ethically appropriate reaction to incidental imaging findings in brain research" , suggested by thomas heinemann, institut für wissenschaft und ethik, and christian hoppe, klinik für epileptologie, universität bonn, germany, on january 9, 2009. Clin Neuroradiol 2009, 19(2):108-110.
168. Illes J, Kirschen MP, Edwards E, Stanford LR, Bandettini P, Cho MK, Ford PJ, Glover GH, Kulynych J, Macklin R, Michael DB, Wolf SM. Incidental findings in brain imaging research. Science 2006, 311:783-784. 10.1126/science.1124665, 1524853, 16469905.
169. Racine E, Bar-Ilan O, Illes J. FMRI in the public eye. Nat Rev Neurosci 2005, 6(2):159-164. 10.1038/nrn1609, 1524852, 15685221.
170. Illes J. Neuroethics in a new era of neuroimaging. Am J Neuroradiol 2003, 24:1739-1741.
171. Tarran B. Eight firms to take part in ARF neuroscience validation study http://www.research-live.com/news/technology/eight-firms-to-take-part-in-arf-%20neuroscience-validation-study/4003667.article.
172. ESOMAR http://www.esomar.org/news-and-multimedia.php?pages=&idnews=57.
173. NMSBA http://www.neuromarketing-association.com/ethics.
174. Ruskin G. Commercial alert asks feds to investigate neuromarketing research at Emory university http://www.commercialalert.org/news/news-releases/2003/12/commercial-alert-asks-feds-to-investigate-neuromarketing-research-at-emory-university.
175. Eser Z, Bahar Isin F, Tolon M. Perceptions of marketing academics, neurologists, and marketing professionals about neuromarketing. J Mark Manag 2011, 27:854-868.
176. Fecteau S, Knoch D, Fregni F, Sultani N, Boggio P, Pascual-Leone A. Diminishing risk-taking behavior by modulating activity in the prefrontal cortex: a direct current stimulation study. J Neurosci 2007, 27:12500-5. 10.1523/JNEUROSCI.3283-07.2007, 18003828.
177. Camus M, Halelamien N, Plassmann H, Shimojo S, O'Doherty J, Camerer C, Rangel A. Repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex decreases valuations during food choices. Eur J Neurosci 2009, 30:1980-1988. 10.1111/j.1460-9568.2009.06991.x, 19912330.
178. Friedman HH, Lopez-Pumarejo T, Friedman LW. Frontiers in multicultural marketing: the disabilities market. Journal of International Marketing and Marketing Research 2007, 32(1):25-39.